There are promising biomarkers for lung cancer diagnosis, such as TTF1 (thyroid transcription factor 1), folate receptor-positive circulating tumor cells [43, 44], but no lncRNAs are ready for broad clinical application [45], which calls for more exploration into the function and mechanism of lncRNAs. This evidence concerns the gene NKX2-1 and lung cancer.